AnPac Bio-Medical Science Co. Ltd. (NASDAQ:ANPC) previous close was $4.58 while the outstanding shares total 11.96M. ANPC’s shares traded lower over the last trading session, losing -15.50% on 06/21/21. The shares fell to a low of $3.87 before closing at $3.87. Intraday shares traded counted 1.86 million, which was -72.42% lower than its 30-day average trading volume of 1.08M. The stock’s Relative Strength Index (RSI) is 33.74, with weekly volatility at 10.05% and ATR at 0.37. The ANPC stock’s 52-week price range has touched low of $3.15 and a $12.09 high.
Investors have identified the Biotechnology company AnPac Bio-Medical Science Co. Ltd. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $46.32 million, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
AnPac Bio-Medical Science Co. Ltd. (ANPC) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. For ANPC, the company has in raw cash 1.38 million on their books with 3.42 million currently as liabilities. How the trend is over time is what investors should be concerned about. The company has a healthy balance sheet as their debt profile has been on an incline. In terms of their assets, the company currently has 5.08 million total, with 7.59 million as their total liabilities.
Potential earnings growth for AnPac Bio-Medical Science Co. Ltd. (ANPC)
What matters though is how it ends. When the core data for the company is broken down, then the stock sounds interesting. The company spent 0.14 million trying to sell their products during the last quarter, with the result yielding a gross income of 0.19 million. This allows shareholders to hold on to 11.96M with the recently reported earning now reading -0.37 cents per share. This is a figure that compared to analyst’s prediction for their 09/16/2021 (-0.37 cents a share).
Having a look at the company’s valuation, the company is expected to record -0.38 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on ANPC sounds very interesting.
Is the stock of ANPC attractive?
In the last 6 months, insiders have changed their ownership in shares of company stock by 32.22%.
1 out of 1 analysts covering the stock have rated it a Buy, while 0 have maintained a Hold recommendation on AnPac Bio-Medical Science Co. Ltd.. 0 analysts has assigned a Sell rating on the ANPC stock. The 12-month mean consensus price target for the company’s shares has been set at $8.00.